What is MapLight Therapeutics, Inc. 's gain/loss on asset sales?

MapLight Therapeutics, Inc. (MPLT) reported gain/loss on asset sales of -$4K in Q1 2026.

How has MapLight Therapeutics, Inc. 's gain/loss on asset sales changed year-over-year?

MapLight Therapeutics, Inc. 's gain/loss on asset sales decreased by 128.6% year-over-year, from -$1.75K to -$4K.

What does gain/loss on asset sales mean?

Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.

MapLight Therapeutics, Inc. MPLT Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

LBR

LB Pharmaceuticals Inc Common StockLBRX

$0-100%

MeiraGTx Holdings plcMGTX

-$55K-145%

Alto NeuroscienceANRO

-$9K+78.0%

Zevra Therapeutics, Inc.ZVRA

$43.31M—

SchrodingerSDGR

-$11K—

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B+100%

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's gain/loss on asset sales?: MapLight Therapeutics, Inc. (MPLT) reported gain/loss on asset sales of -$4K in Q1 2026.
How has MapLight Therapeutics, Inc. 's gain/loss on asset sales changed year-over-year?: MapLight Therapeutics, Inc. 's gain/loss on asset sales decreased by 128.6% year-over-year, from -$1.75K to -$4K.
What does gain/loss on asset sales mean?: Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.